Lakhanpal V
Department of Ophthalmology, University of Maryland at Baltimore.
Trans Am Ophthalmol Soc. 1993;91:545-652.
We have been able to create a reproducible experimental model of nonexpulsive massive suprachoroidal hemorrhage in a rabbit eye. Massive suprachoroidal hemorrhage was demonstrated on echography and confirmed on histopathologic examination in all eyes. The natural course of the disease suggests that there is very little change in the size of the choroidal detachment in the first 7 days. Maximum liquefaction of the suprachoroidal hemorrhage clot was seen to occur between 7 and 14 days. However, increased retinal and ciliary body atrophy was also noted at 14 days. Therefore, the optimum time to drain massive suprachoroidal hemorrhage appears to be between 7 and 14 days. Immediate sclerotomy during the acute formation of massive suprachoroidal hemorrhage resulted in further increase in the suprachoroidal hemorrhage, with marked extension of the hemorrhage into the retina and vitreous. Therefore, in our opinion, immediate sclerotomy during massive suprachoroidal hemorrhage is detrimental to the eye. Our clinical data have shown that eyes with massive suprachoroidal hemorrhage can be treated successfully by secondary surgery, and the majority of the eyes can be salvaged with good visual results. No serious complications of this surgery were encountered in our cases. We advocate early surgical intervention between 7 and 14 days. Aggressive anterior and posterior segment reconstruction by anterior and posterior vitrectomy after sclerotomy drainage of the suprachoroidal hemorrhage is essential for better anatomic and visual results. Our animal data and clinical experience suggest that the optimum time of drainage of massive suprachoroidal hemorrhage is between 7 and 14 days. The results of our animal experiments in relation to human clinical application should be taken with caution. Furthermore, we had a small number of animals to study the various groups. In addition, longer follow-up may be needed for comparing controls with the treatment groups. Our animal model may help in such future studies on massive suprachoroidal hemorrhage.
我们已经能够在兔眼中创建一种可重复的非搏动性大量脉络膜上腔出血的实验模型。所有眼睛在超声检查中均显示有大量脉络膜上腔出血,并经组织病理学检查证实。该疾病的自然病程表明,在最初7天内脉络膜脱离的大小变化很小。脉络膜上腔出血凝块的最大液化出现在7至14天之间。然而,在14天时也注意到视网膜和睫状体萎缩增加。因此,引流大量脉络膜上腔出血的最佳时间似乎在7至14天之间。在大量脉络膜上腔出血急性形成期间立即进行巩膜切开术会导致脉络膜上腔出血进一步增加,出血明显扩展至视网膜和玻璃体。因此,我们认为,在大量脉络膜上腔出血期间立即进行巩膜切开术对眼睛有害。我们的临床数据表明,大量脉络膜上腔出血的眼睛可以通过二次手术成功治疗,大多数眼睛可以挽救并获得良好的视力结果。我们的病例中未遇到该手术的严重并发症。我们主张在7至14天之间进行早期手术干预。在巩膜切开引流脉络膜上腔出血后,通过前后玻璃体切除术进行积极的前段和后段重建对于获得更好的解剖和视力结果至关重要。我们的动物数据和临床经验表明,大量脉络膜上腔出血的最佳引流时间在7至14天之间。我们动物实验结果与人类临床应用的相关性应谨慎对待。此外,我们用于研究各个组别的动物数量较少。另外,可能需要更长时间的随访来比较对照组和治疗组。我们的动物模型可能有助于未来关于大量脉络膜上腔出血的研究。